HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hemopneumothorax in a COPD patient treated with noninvasive positive pressure ventilation: the risk of attendant anticoagulation.

Abstract
Noninvasive positive pressure ventilation (NIPPV) modalities have been proven to be effective in the setting of exacerbations of chronic obstructive pulmonary disease (COPD). Reported complications include pneumothorax, increased work of breathing, gastric distension and air embolism. This case demonstrates that patients with severe COPD on anticoagulant therapy are potentially at risk for the serious complication of combined lung barotrauma and hemorrhage while on acute NIPPV therapy. This is the first reported case of hemopneumothorax complicating NIPPV therapy.
AuthorsR Raghavan, A K Ellis, W Wobeser, K B Sutherland, D E O'Donnell
JournalCanadian respiratory journal (Can Respir J) Vol. 11 Issue 2 Pg. 159-62 (Mar 2004) ISSN: 1198-2241 [Print] Egypt
PMID15045048 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anticoagulants
Topics
  • Aged
  • Aged, 80 and over
  • Anticoagulants (adverse effects)
  • Hemopneumothorax (diagnostic imaging, etiology)
  • Hemorrhage (chemically induced, etiology)
  • Humans
  • Male
  • Pneumothorax (diagnostic imaging, etiology)
  • Positive-Pressure Respiration (adverse effects)
  • Pulmonary Disease, Chronic Obstructive (complications, diagnostic imaging, therapy)
  • Radiography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: